The phrase "acquired risks" is correct and usable in written English.
It can be used in contexts discussing risks that have been obtained or assumed, often in relation to investments, health, or safety.
Example: "Investors should be aware of the acquired risks associated with emerging markets before committing their funds."
Alternatives: "assumed risks" or "inherent risks".
At present, recognized acquired risks for AD include traumatic brain injury, hypercholesterolemia, obesity, hypertension, and type 2 diabetes.
These authors argue from a public health point of view that acquired risks or exposures are associated with an increased likelihood that a disease will develop later.
Connell's theory of gender and power was further developed by Wingood and DiClemente (14) into a public health model by arguing that gender-based inequities and differences in expectations generate the exposures, or acquired risks, and the risk factors that negatively impact on the health of women.
The literature of aging studies has long recognized a gender paradox in health and mortality, and it is argued that gender differences in genetic and acquired risks, immune system responses, hormones, disease patterns and prevention, and health-reporting behaviors may explain the poorer health and lower mortality of women than men [ 40].
Different acquired risk factors as smoking or overweightness are identified.
In the process of gaining responsibility, Holyrood has also acquired risk.
Hereditary and acquired risk factors increase the risk for thrombosis among pregnant women.
Other inherited and acquired risk factors were similarly distributed among cases and controls.
Objective: To establish the prevalence of inherited and acquired risk factors for development of venous thromboembolism (VTE) in pregnancy and the puerperium.
Future studies should determine the contribution of inherited and other acquired risk factors for thrombosis and assess measures to prevent and/or treat catheter-related thrombosis in this population.
In a note to clients, the Sanford C. Bernstein analyst Ronny Gal calculated that Elan had severely overpaid for the drugs, stating that it was "tough to see how the assets acquired, risk discounted, would command such a value".
